| Price | $1.13 |
| Year Range | $1.05 – $14.04 |
| Market Cap | $2.8M |
| Industry | Health Care Services |
What Is iSpecimen’s AI Stock Analysis?
iSpecimen’s AI stock analysis on AltIndex combines the company’s fundamentals, price technicals and 25+ alternative data signals — like hiring, web traffic, app downloads and online sentiment — into a single AI Score from 0 to 100 and a plain-English Buy, Hold or Sell read. Unlike a traditional analyst rating that updates a few times a year, the AI Score refreshes as new data arrives, so it tracks iSpecimen’s momentum in near-real time.
iSpecimen (ISPC) has an AltIndex AI Score of 38/100, currently a Sell signal. The AI Score distills iSpecimen's fundamentals, price technicals and 25+ alternative data signals into a single 0–100 rating, so a rising score reflects strengthening data across the board and a falling score the opposite.
iSpecimen’s Full AI Analysis
Keep reading AltIndex’s full AI analysis of iSpecimen — the fundamental, technical and alternative-data breakdown and the recommendation.
Sign up to read the full analysisWhat’s Driving ISPC’s AI Score?
Fundamentals
Revenue for the last quarter was $150,000. This represents a decrease of 2.61% compared to the quarter before it, indicating a need for concern. However, compared to the same quarter last year, there is a decrease of 78.69%, which may be a cause for concern. Ebitda for the last quarter was $-1.4M. This is an increase of -36.25% compared to the quarter before it, which is a positive sign of growth. However, compared to the same quarter last year, there is a decrease of 121.80%, which may be a cause for concern.
See iSpecimen’s earnings and insider transactions.
Technicals
Today's stock price is $1.13. This represents a decrease of 23.13% compared to a month ago, which may be concerning in the short-term. However, compared to a year ago, there is a decrease of 96.75%, which could be a cause for long-term concern. The trend is bearish. The current SMA10 is $1.10, which is lower than the previous SMA10 of $1.10. This suggests a potential downward trend in price movement. The RSI is 46.2, indicating a neutral condition.
See the full technical analysis and price prediction.
Alternative data
The business outlook among employees at iSpecimen is low (an estimate of only 37% of employees have a positive outlook), a concerning sign. iSpecimen has an estimate of 1,000 visitors to their webpage. The number of visitors is down by -67% in the last couple of months, a worrisome trend as this can indicate a loss in customers.
Explore iSpecimen’s job postings, web traffic and app downloads.
Frequently Asked Questions: iSpecimen AI Stock Analysis
iSpecimen's AltIndex AI Score is 38/100, currently a Sell signal. The AI Score blends fundamentals, technicals and 25+ alternative data signals into a single rating from 0 to 100.
AltIndex's AI Score model rates iSpecimen a Sell (38/100). This is a data-driven signal, not investment advice — review the breakdown above and combine it with your own research.
The AI Score is generated from fundamental data (earnings, valuation), technical indicators (price trend and momentum), and alternative data signals such as hiring, web traffic, app downloads and sentiment. AltIndex weighs these into a single 0-100 score; the exact weighting is proprietary.
AltIndex generates a complete written AI analysis of iSpecimen — company overview, fundamentals, technicals and alternative data, with a recommendation. See the ISPC AI Score or sign up to read the full thesis.
